Register entry

Resilience Biotechnologies Inc.

Data as of · How to read this entry

Registered sites
2
Active NDC listings
1
Live patents
0
Countries
1
Base
Canada
Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1Finished drug manufacture2Packaging1
Sites

Registered establishments

2
EstablishmentAddressRegistered forFEI / DUNS
Resilience Biotechnologies Inc.420 Ambassador Drive, Mississauga, ON L5T 2J3, Canada (CAN)Finished drug manufacture3012411724243348734
Resilience Biotechnologies, Inc.Registrant: Resilience Biotechnologies Inc.2585 Meadowpine Blvd., Mississauga, Ontario L5N8H9, Canada (CAN)Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture, Packaging3007503037243669426
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
-Amikacin Liposome Inhalation Suspensionsuspension72770-7032DRUG FOR FURTHER PROCESSING
Neighbours

Registered in the same town

11
Compare

Comparable companies in Canada

Enquiry

Common questions

Is Resilience Biotechnologies Inc. FDA approved?
Resilience Biotechnologies Inc. holds 2 FDA-registered establishments in Canada. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Resilience Biotechnologies Inc.'s drugs manufactured?
The FDA register lists Mississauga. Registered operations: analytical testing, active ingredient (API) manufacture, finished drug manufacture, packaging.
What drugs does Resilience Biotechnologies Inc. make?
1 product is listed under Resilience Biotechnologies Inc. in the openFDA NDC Directory, most often as suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.